🔴 Adaptive Biotechnologies is trading 4.16% down today on profit-taking and broader biotech sector weakness

Adaptive Biotechnologies is trading at $20.95 (-4.16%) following a sharp pullback from a recent rally that pushed the stock toward 52-week highs.

• The decline is driven by profit-taking after a significant multi-day run, alongside a broader retreat in the biotech sector with the XBI down 2.04%.
• Shares continue to consolidate following the company’s recent announcement of a $250 million convertible notes offering and a strategic business separation.
• The move represents a technical reversal as the stock cools off from overbought levels reached during its recent upward momentum.